Here's how much $5,000 invested on Monday in marijuana stock Stemcell Utd Ltd would be worth today

Is the Stemcell Utd Ltd (ASX:SCU) share price really good value?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's the company that's gone gangbusters on the coronation of the "Cannabis King" as it's official adviser and it's likely to have made some lucky investors rather rich.

Earlier in March the Stemcell Utd Ltd (ASX: SCU) share price was trading at around 1.3 cents per share, but closed today at 37 cents per share on traders' excitement over little more than its fast-rising share price.

In fact the Stemcell Utd share price hit a high of $1.08 today on a market value of more than $300 million in a scenario that can only be attributed to some wild trading that would have kept many speculators glued to their screens.

The sum of $5,000 invested in Stemcell shares at 1.3 cents per share in early March would have earned you 384,615 shares worth around $142,307 at the close of trade today, or nearly $400,000 if you had managed to sell at the top of today's trade.

There's no doubt that those are some impressive returns, but in truth your chances of striking it rich on a penny stock are only slightly better than your chances of being struck by lightning twice – on the same day.

For that reason I would suggest you ignore the fortune-losing penny stocks to focus on stocks where you can make a real world fortune.

So forget the pot stocks and focus on high-quality profitable businesses with long track records, as it's not hard to make serious money in the stock market as long as you let time do the heavy lifting.

So why not look to healthcare companies that are the real deal when it comes to creating retirement-making fortunes?

Such as CSL Limited (ASX: CSL) or Cochlear Limited (ASX: RHC). Both have delivered giant capital gains while paying dividends over the past 10 years. And I expect they have plenty of room to run in the decade ahead.

Motley Fool contributor Tom Richardson owns shares of Cochlear Ltd. and CSL Ltd. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »